Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

23.48USD
11 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$23.48
Open
$23.78
Day's High
$24.54
Day's Low
$23.23
Volume
83,079
Avg. Vol
154,532
52-wk High
$46.12
52-wk Low
$19.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.971
Jun '18 0.00 -0.849
Mar '18 0.00 -0.739
FY 2017 Dec '17 0.00 -0.162
Sep '17 0.00 -0.881
Jun '17 0.00 -0.867
Mar '17 0.00 -0.833
FY 2016 Dec '16 0.00 -0.902
Sep '16 0.00 -0.936
Jun '16 0.00 -0.674
Mar '16 0.00 -0.498
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 11 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 8 0.00 0.00 0.00 --
Year Ending Dec-18 14 0.00 0.00 0.00 0.00
Year Ending Dec-19 14 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 14 -0.90 -0.79 -1.02 -0.94
Quarter Ending Mar-19 9 -0.94 -0.82 -1.04 -0.85
Year Ending Dec-18 14 -3.43 -3.06 -3.60 -3.66
Year Ending Dec-19 14 -3.86 -3.28 -4.53 -3.48
LT Growth Rate (%) 1 3.90 3.90 3.90 -1.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.37 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) 4.46 15.60 5.12
Price to Tangible Book (MRQ) 4.80 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 91.92 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -28.79 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -78.74 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 10.06 5.42 3.11
LT Debt to Equity (MRQ) 2.39 33.58 11.47
Total Debt to Equity (MRQ) 2.48 35.41 15.63
Interest Coverage (TTM) -- -152.90 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.20
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.72 11.83
Operating Margin (TTM) -- -728.64 4.90
Operating Margin - 5 Yr. Avg. -- -526.20 7.44
Pre-Tax Margin (TTM) -- -694.91 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.69 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.51 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,735 898,898,415
Net Income/Employee (TTM) -782,464 2,194,099 106,547,429
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.50 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -57.99 0.29 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -145.70 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -344.14 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Audentes Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.49 7.64 71 57
13 Week 34.00 27.48 83 61
26 Week 60.95 48.72 85 81
52 Week 43.62 21.73 74 47
YTD 42.36 25.02 70 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.12%
# of Holders: 183
Total Shares Held: 40,180,786
3 Mo. Net Change: -52,365
# New Positions: 14
# Closed Positions: 21
# Increased Positions: 74
# Reduced Positions: 67
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.